Examining development and object permanence in high-risk infants
Investigation of the Relationship Between Development, Neurological Assessment and Object Permanence in High Risk Infants.
Tokat Gaziosmanpasa University · NCT05749796
This study is testing how development and understanding of object permanence are connected in infants aged 7-16 months who are at risk due to factors like being born early or having a low birth weight.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 32 (estimated) |
| Ages | 7 Months to 16 Months |
| Sex | All |
| Sponsor | Tokat Gaziosmanpasa University (other) |
| Locations | 1 site (Tokat) |
| Trial ID | NCT05749796 on ClinicalTrials.gov |
What this trial studies
This study investigates how development, neurological assessments, and object permanence are related in infants aged 7-16 months who are considered at risk due to factors like preterm birth or low birth weight. The research involves assessing infants using standardized scales such as the Bayley III infant and toddler development scale and the Hammersmith infant neurologic assessment. Parents will provide demographic information to support the study's findings. The goal is to better understand developmental challenges in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are infants aged 7-16 months who have at least one identified risk factor.
Not a fit: Patients with severe medical complications or specific neurodevelopmental disorders will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights that lead to improved developmental support for high-risk infants.
How similar studies have performed: While similar studies have explored aspects of infant development, this specific investigation into the relationship between neurological assessment and object permanence in high-risk infants is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between 7-16 months, having at least one risk factor Exclusion Criteria: * Medical complications (eg, severe visual impairment) limiting participation in assessments; autism, down syndrome, or spinal cord injury; diagnosed uncontrolled seizure disorder; or a neurodegenerative disorder
Where this trial is running
Tokat
- Faculty of Health Sciences, Tokat Gaziosmanpaşa University — Tokat, Turkey (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Infant Development